Latest Articles

Keep up to date with the latest advancements in regenerative medicine.

Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice

Regenerative Medicine

25/05/2020

This research paper discuss Type 2 diabetes and how NAD+ biosynthesis is crtical to the process as well as supplementation outcomes.

READ ARTICLE

Categories

NAD+ (15)
Stem Cells (6)

Tags

Health

NAD+

Recent Posts

Regenerative Medicine Co., Ltd. Proudly Announces Exclusive Partnership for InfiNADi NAD+ Products in Vietnam
June 27, 2024Regenerative Medicine

Regenerative Medicine Co., Ltd. Proudly Announces Exclusive Partnership for InfiNADi NAD+ Products in Vietnam

Regenerative Medicine June 27, 2024

NAD+ Repletion Rescues Female Fertility during Reproductive Aging

Regenerative Medicine August 25, 2020

Popular Posts

Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19

Regenerative Medicine August 20, 2020

NAD+ Repletion Rescues Female Fertility during Reproductive Aging

Regenerative Medicine August 25, 2020

The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson’s Disease

Regenerative Medicine June 7, 2020

Start a conversation

Your trusted biomedicine provider since 2007.

PRODUCTS

Quick Links

Copyright @ Regenerative Medicine Co, Ltd. All Rights Reserved